Answer in brief
CVE-2026-67558 records a Unknown severity vulnerability in Mira Hormone Monitor, Mira Android App Authentication bypass by spoofing. The current sources do not mark it as known exploited. The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
A CVSS score is not reported in the current record. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android Appgeneric | 4.5.15.4 | Not reported |
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmwaregeneric | 1.7.1.47 | Not reported |
Published upstream
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Aug 11, 2026
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
Quoted source text, attributed separately from HOL analysis.
Answer in brief
CVE-2026-67558 records a Unknown severity vulnerability in Mira Hormone Monitor, Mira Android App Authentication bypass by spoofing. The current sources do not mark it as known exploited. The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
A CVSS score is not reported in the current record. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android App (generic), Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmware (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Android Appgeneric | 4.5.15.4 | Not reported |
| Quanovate Tech Inc. (operating as Mira / Mira Care)/Mira Firmwaregeneric | 1.7.1.47 | Not reported |
Published upstream
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Aug 11, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Aug 11, 2026
The Mira Android companion app v4.5.15.4 identifies the paired Mira hormone analyzer by performing a substring match against the BLE advertisement name only, with no cryptographic peripheral authentication, MAC allowlist, or bonded-identity check. An attacker could capture live session token information and inject forged hormone measurements into the victim's cloud record and clinical trend view.
Quoted source text, attributed separately from HOL analysis.